ProBiotix Health Plc (AQU:PBX)
9.00
0.00 (0.00%)
At close: Jun 8, 2026
ProBiotix Health Company Description
ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.
The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction.
It also provides YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support.
The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022.
The company was founded in 2012 and is based in Wakefield, the United Kingdom.
ProBiotix Health Plc
| Country | United Kingdom |
| Founded | 2012 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 12 |
| CEO | Steen Andersen |
Contact Details
Address: First Floor Zucchi Suite Wakefield, WF4 1AB United Kingdom | |
| Website | probiotixhealth.com |
Stock Details
| Ticker Symbol | PBX |
| Exchange | Aquis Exchange |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Steen Andersen | Chief Executive Officer |